MYCOBACTERIUM - ANVISA Registration 10071770704

Access comprehensive regulatory information for MYCOBACTERIUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10071770704 and manufactured by ABBOTT DIAGNOSTICS KOREA INC.. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until Oct 27, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HAIN LIFESCIENCE GMBH, BECTON DICKINSON AND COMPANY (SPARKS), and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10071770704
2 Related Devices
Registration Details
ANVISA Registration Number: 10071770704
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

BIOLINE TB Ag MPT64 Rapid
Risk Class III

Registration Details

10071770704

25351135096201386

50248780000161

Company Information

South Korea
PT: CORÉIA DO SUL

Dates and Status

May 20, 2013

27/10/2033

09/18/2025 19:00:01

BIOLINE TB Ag MPT64 Rapid
Risk Class III

Registration Details

10071770704

25351135096201386

50248780000161

Company Information

Dates and Status

May 20, 2013

27/10/2033

09/18/2025 19:00:01